-
1
-
-
0029853403
-
Minimal residual disease: Detection, clinical relevance, and treatment strategies
-
Dwenger, A., Lindemann, A., and Mertelsmann, R. Minimal residual disease: detection, clinical relevance, and treatment strategies. J. Hematother., 5: 537-548, 1996.
-
(1996)
J. Hematother.
, vol.5
, pp. 537-548
-
-
Dwenger, A.1
Lindemann, A.2
Mertelsmann, R.3
-
2
-
-
0023754537
-
Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor
-
Itoh, K., Platsoucas, C. D., and Balch, C. M. Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor. J. Exp. Med., 168: 1419-1441, 1988.
-
(1988)
J. Exp. Med.
, vol.168
, pp. 1419-1441
-
-
Itoh, K.1
Platsoucas, C.D.2
Balch, C.M.3
-
3
-
-
0024391086
-
Characterization of the CD4+ and CD8+ tumor infiltrating lymphocytes propagated with bispecific monoclonal antibodies
-
Wong, J. T., Pinto, C. E., Gifford, J. D., Kurnick, J. T., and Kradin, R. L. Characterization of the CD4+ and CD8+ tumor infiltrating lymphocytes propagated with bispecific monoclonal antibodies. J. Immunol., 143: 3404-3411, 1989.
-
(1989)
J. Immunol.
, vol.143
, pp. 3404-3411
-
-
Wong, J.T.1
Pinto, C.E.2
Gifford, J.D.3
Kurnick, J.T.4
Kradin, R.L.5
-
4
-
-
0027743537
-
Tumor escape mechanisms from immunosurveillance: Induction of unresponsiveness in a specific MHC-restricted CD4+ human T cell clone by the autologous MHC class II+ melanoma
-
Becker, J. C., Brabletz, T., Czerny, C., Termeer, C., and Brocker, E. B. Tumor escape mechanisms from immunosurveillance: induction of unresponsiveness in a specific MHC-restricted CD4+ human T cell clone by the autologous MHC class II+ melanoma. Int. Immunol., 5: 1501-1508, 1993.
-
(1993)
Int. Immunol.
, vol.5
, pp. 1501-1508
-
-
Becker, J.C.1
Brabletz, T.2
Czerny, C.3
Termeer, C.4
Brocker, E.B.5
-
5
-
-
0030824806
-
T helper 2-dominant antilymphoma immune response is associated with fatal outcome
-
Lee, P. P., Zeng, D., McCaulay, A. E., Chen, Y. F., Geiler, C., Umetsu, D. T., and Chao, N. J. T helper 2-dominant antilymphoma immune response is associated with fatal outcome. Blood, 90: 1611-1617, 1997.
-
(1997)
Blood
, vol.90
, pp. 1611-1617
-
-
Lee, P.P.1
Zeng, D.2
McCaulay, A.E.3
Chen, Y.F.4
Geiler, C.5
Umetsu, D.T.6
Chao, N.J.7
-
6
-
-
0032169984
-
Antigen expressed on tumor cells fails to elicit an immune response, even in the presence of increased numbers of tumor-specific cytotoxic T lymphocyte precursors
-
Hermans, I. F., Daish, A., Yang, J., Ritchie, D. S., and Ronchese, F. Antigen expressed on tumor cells fails to elicit an immune response, even in the presence of increased numbers of tumor-specific cytotoxic T lymphocyte precursors. Cancer Res., 58: 3909-3917, 1998.
-
(1998)
Cancer Res.
, vol.58
, pp. 3909-3917
-
-
Hermans, I.F.1
Daish, A.2
Yang, J.3
Ritchie, D.S.4
Ronchese, F.5
-
7
-
-
0025161953
-
Preliminary trial of specific targeting therapy against malignant glioma
-
Nitta, T., Sato, K., Yagita, H., Okumura, K., and Ishii, S. Preliminary trial of specific targeting therapy against malignant glioma. Lancet., 335: 368-371, 1990.
-
(1990)
Lancet
, vol.335
, pp. 368-371
-
-
Nitta, T.1
Sato, K.2
Yagita, H.3
Okumura, K.4
Ishii, S.5
-
8
-
-
0029117559
-
Regression of advanced ovarian carcinoma by intraperitoneal treatment with autologous T lymphocytes retargeted by a bispecific monoclonal antibody
-
Canevari, S., Stoter, G., Arienti, F., Bolis, G., Colnaghi, M. I., Di Re, E. M., Eggermont, A. M., Goey, S. H., Gratama, J. W., Lamers, C. H., Nooy, M. A., Parmiani, G., Raspagliesi, F., Ravagnani, F., Scarfone, G., Trimbos, J. B., Warnaar, S. O., and Bolhuis, R. L. Regression of advanced ovarian carcinoma by intraperitoneal treatment with autologous T lymphocytes retargeted by a bispecific monoclonal antibody. J. Natl. Cancer Inst., 87: 1463-1469, 1995.
-
(1995)
J. Natl. Cancer Inst.
, vol.87
, pp. 1463-1469
-
-
Canevari, S.1
Stoter, G.2
Arienti, F.3
Bolis, G.4
Colnaghi, M.I.5
Di Re, E.M.6
Eggermont, A.M.7
Goey, S.H.8
Gratama, J.W.9
Lamers, C.H.10
Nooy, M.A.11
Parmiani, G.12
Raspagliesi, F.13
Ravagnani, F.14
Scarfone, G.15
Trimbos, J.B.16
Warnaar, S.O.17
Bolhuis, R.L.18
-
9
-
-
0028122745
-
Phase I study of intravenously applied bispecific antibody in renal cell cancer patients receiving subcutaneous interleukin 2
-
Kroesen, B. J., Buter, J., Sleijfer, D. T., Janssen, R. A., van der Graaf, W. T., The, T. H., De Leij, L., and Mulder, N. H. Phase I study of intravenously applied bispecific antibody in renal cell cancer patients receiving subcutaneous interleukin 2. Br. J. Cancer, 70: 652-661, 1994.
-
(1994)
Br. J. Cancer
, vol.70
, pp. 652-661
-
-
Kroesen, B.J.1
Buter, J.2
Sleijfer, D.T.3
Janssen, R.A.4
Van Der Graaf, W.T.5
The, T.H.6
De Leij, L.7
Mulder, N.H.8
-
10
-
-
0027817577
-
Cytolysis of leukemic B-cells by T-cells activated via two bispecific antibodies
-
Bohlen, H., Manzke, O., Patel, B., Moldenhauer, G., Dorken, B., von Fliedner, V., Diehl, V., and Tesch, H. Cytolysis of leukemic B-cells by T-cells activated via two bispecific antibodies. Cancer Res., 53: 4310-4314, 1993.
-
(1993)
Cancer Res.
, vol.53
, pp. 4310-4314
-
-
Bohlen, H.1
Manzke, O.2
Patel, B.3
Moldenhauer, G.4
Dorken, B.5
Von Fliedner, V.6
Diehl, V.7
Tesch, H.8
-
11
-
-
0030466658
-
CD3-CD28 costimulation as a means to avoiding T cell preactivation in bispecific monoclonal antibody-based treatment of ovarian carcinoma
-
Mazzoni, A., Mezzanzanica, D., Jung, G., Wolf, H., Colnaghi, M. I., and Canevari, S. CD3-CD28 costimulation as a means to avoiding T cell preactivation in bispecific monoclonal antibody-based treatment of ovarian carcinoma. Cancer Res., 56: 5443-5449, 1996.
-
(1996)
Cancer Res.
, vol.56
, pp. 5443-5449
-
-
Mazzoni, A.1
Mezzanzanica, D.2
Jung, G.3
Wolf, H.4
Colnaghi, M.I.5
Canevari, S.6
-
12
-
-
0023227850
-
Induction of cytotoxicity in resting human T lymphocytes bound to tumor cells by antibody heteroconjugates
-
Jung, G., Ledbetter, J. A., and Muller-Eberhard, H. J. Induction of cytotoxicity in resting human T lymphocytes bound to tumor cells by antibody heteroconjugates. Proc. Natl. Acad. Sci. USA, 84: 4611-4615, 1987.
-
(1987)
Proc. Natl. Acad. Sci. USA
, vol.84
, pp. 4611-4615
-
-
Jung, G.1
Ledbetter, J.A.2
Muller-Eberhard, H.J.3
-
13
-
-
0026684815
-
Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms
-
Yokota, T., Milenic, D. E., Whitlow, M., and Schlom, J. Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms. Cancer Res., 52: 3402-3408, 1992.
-
(1992)
Cancer Res.
, vol.52
, pp. 3402-3408
-
-
Yokota, T.1
Milenic, D.E.2
Whitlow, M.3
Schlom, J.4
-
14
-
-
0031942906
-
Prolonged in vivo tumor retention of a human diabody targeting the extracellular domain of human HER2/neu
-
Adams, G. P., Schier, R., McCall, A. M., Crawford, R. S., Wolf, E. J., Weiner, L. M., and Marks, J. D. Prolonged in vivo tumor retention of a human diabody targeting the extracellular domain of human HER2/neu. Br. J. Cancer, 77: 1405-1412, 1998.
-
(1998)
Br. J. Cancer
, vol.77
, pp. 1405-1412
-
-
Adams, G.P.1
Schier, R.2
McCall, A.M.3
Crawford, R.S.4
Wolf, E.J.5
Weiner, L.M.6
Marks, J.D.7
-
15
-
-
0029932582
-
Specific killing of lymphoma cells by cytotoxic T-cells mediated by a bispecific diabody
-
Holliger, P., Brissinck, J., Williams, R. L., Thielemans, K., and Winter, G. Specific killing of lymphoma cells by cytotoxic T-cells mediated by a bispecific diabody. Protein Eng., 9: 299-305, 1996.
-
(1996)
Protein Eng.
, vol.9
, pp. 299-305
-
-
Holliger, P.1
Brissinck, J.2
Williams, R.L.3
Thielemans, K.4
Winter, G.5
-
16
-
-
0027197493
-
"Diabodies": Small bivalent and bispecific antibody fragments
-
Holliger, P., Prospero, T., and Winter, G. "Diabodies": small bivalent and bispecific antibody fragments. Proc. Natl. Acad. Sci. USA, 90: 6444-6448, 1993.
-
(1993)
Proc. Natl. Acad. Sci. USA
, vol.90
, pp. 6444-6448
-
-
Holliger, P.1
Prospero, T.2
Winter, G.3
-
17
-
-
0023781763
-
Genetic approach to facilitate purification of recombinant proteins with a novel metal chelate adsorbent
-
Hochuli, E., Bannwarth, W., Dobeli, H., Gentz, R., and Stüber, D. Genetic approach to facilitate purification of recombinant proteins with a novel metal chelate adsorbent. Biotechnology, 6: 1321-1325, 1988.
-
(1988)
Biotechnology
, vol.6
, pp. 1321-1325
-
-
Hochuli, E.1
Bannwarth, W.2
Dobeli, H.3
Gentz, R.4
Stüber, D.5
-
18
-
-
0023052239
-
An Hsp70-like protein in the ER: Identity with the 78 kd glucose-regulated protein and immunoglobulin heavy chain binding protein
-
Munro, S., and Pelham, H. R. An Hsp70-like protein in the ER: identity with the 78 kd glucose-regulated protein and immunoglobulin heavy chain binding protein. Cell, 46: 291-300, 1986.
-
(1986)
Cell
, vol.46
, pp. 291-300
-
-
Munro, S.1
Pelham, H.R.2
-
19
-
-
0031441221
-
Improved tumor targeting by disulphide stabilized diabodies expressed in Pichia pastoris
-
Fitz Gerald, K., Holliger, P., and Winter, G. Improved tumor targeting by disulphide stabilized diabodies expressed in Pichia pastoris. Protein Eng., 10: 1221-1225, 1997.
-
(1997)
Protein Eng.
, vol.10
, pp. 1221-1225
-
-
Fitz Gerald, K.1
Holliger, P.2
Winter, G.3
-
20
-
-
0028043192
-
Differentiation of cytotoxicity using target cells labeled with europium and samarium by electroporation
-
Bohlen, H., Manzke, O., Engert, A., Hertel, M., Hippler-Altenburg, R., Diehl, V., and Tesch, H. Differentiation of cytotoxicity using target cells labeled with europium and samarium by electroporation. J. Immunol. Methods, 173: 55-62, 1994.
-
(1994)
J. Immunol. Methods
, vol.173
, pp. 55-62
-
-
Bohlen, H.1
Manzke, O.2
Engert, A.3
Hertel, M.4
Hippler-Altenburg, R.5
Diehl, V.6
Tesch, H.7
-
22
-
-
0022602899
-
Mapping epitope characteristics on carcinoembryonic antigen
-
Harwood, P. J., Britton, D. W., Southall, P. J., Boxer, G. M., Rawlins, G., and Rogers, G. T. Mapping epitope characteristics on carcinoembryonic antigen. Br. J. Cancer, 54: 75-82, 1986.
-
(1986)
Br. J. Cancer
, vol.54
, pp. 75-82
-
-
Harwood, P.J.1
Britton, D.W.2
Southall, P.J.3
Boxer, G.M.4
Rawlins, G.5
Rogers, G.T.6
-
23
-
-
0030039532
-
High level secretion of a humanized bispecific diabody from Escherichia coli
-
NY
-
Zhu, Z., Zapata, G., Shalaby, R., Snedecor, B., Chen, H., and Carter, P. High level secretion of a humanized bispecific diabody from Escherichia coli. Biotechnology (NY), 14: 192-196, 1996.
-
(1996)
Biotechnology
, vol.14
, pp. 192-196
-
-
Zhu, Z.1
Zapata, G.2
Shalaby, R.3
Snedecor, B.4
Chen, H.5
Carter, P.6
-
24
-
-
0032513528
-
Construction and characterization of a bispecific diabody for retargeting T cells to human carcinomas
-
Helfrich, W., Kroesen, B. J., Roovers, R. C., Westers, L., Molema, G., Hoogenboom, H. R., and de Leij, L. Construction and characterization of a bispecific diabody for retargeting T cells to human carcinomas. Int. J. Cancer, 76: 232-239, 1998.
-
(1998)
Int. J. Cancer
, vol.76
, pp. 232-239
-
-
Helfrich, W.1
Kroesen, B.J.2
Roovers, R.C.3
Westers, L.4
Molema, G.5
Hoogenboom, H.R.6
De Leij, L.7
-
25
-
-
0028358417
-
Prognosis of elderly patients with large bowel cancer
-
Mulcahy, H. E., Patchett, S. E., Daly, L., and O'Donoghue, D. P. Prognosis of elderly patients with large bowel cancer. Br. J. Surg., 81: 736-738, 1994.
-
(1994)
Br. J. Surg.
, vol.81
, pp. 736-738
-
-
Mulcahy, H.E.1
Patchett, S.E.2
Daly, L.3
O'Donoghue, D.P.4
-
26
-
-
0028224082
-
Randomized trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma
-
German Cancer Aid 17-1A Study Group
-
Riethmuller, G., Schneider-Gadicke, E., Schlimok, G., Schmiegel, W., Raab, R., Hoffken, K., Gruber, R., Pichlmaier, H., Hirche, H., Pichlmayr, R., Bruggish, P., Witte, J., and the German Cancer Aid 17-1A Study Group. Randomized trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group. Lancet, 343: 1177-1183, 1994.
-
(1994)
Lancet
, vol.343
, pp. 1177-1183
-
-
Riethmuller, G.1
Schneider-Gadicke, E.2
Schlimok, G.3
Schmiegel, W.4
Raab, R.5
Hoffken, K.6
Gruber, R.7
Pichlmaier, H.8
Hirche, H.9
Pichlmayr, R.10
Bruggish, P.11
Witte, J.12
-
27
-
-
0023126589
-
The use of hybrid hybridomas to target human cytotoxic T lymphocytes
-
Lanzaveccia, A., and Scheidegger, D. The use of hybrid hybridomas to target human cytotoxic T lymphocytes. Eur. J. Immunol., 17: 105-111, 1987.
-
(1987)
Eur. J. Immunol.
, vol.17
, pp. 105-111
-
-
Lanzaveccia, A.1
Scheidegger, D.2
-
28
-
-
0025910046
-
Treatment of murine B cell lymphoma with bispecific monoclonal antibodies (anti-idiotype x anti-CD3)
-
Demanet, C., Brissinck, J., Van, M. M., Leo, O., and Thielemans, K. Treatment of murine B cell lymphoma with bispecific monoclonal antibodies (anti-idiotype x anti-CD3). J. Immunol., 147: 1091-1097, 1991.
-
(1991)
J. Immunol.
, vol.147
, pp. 1091-1097
-
-
Demanet, C.1
Brissinck, J.2
Van, M.M.3
Leo, O.4
Thielemans, K.5
-
29
-
-
0025746633
-
Bispecific anti-idiotype/anti-CD3 antibody therapy of murine B cell lymphoma
-
Weiner, G. J., and Hillstrom, J. R. Bispecific anti-idiotype/anti-CD3 antibody therapy of murine B cell lymphoma. J. Immunol., 147: 4035-4044, 1991.
-
(1991)
J. Immunol.
, vol.147
, pp. 4035-4044
-
-
Weiner, G.J.1
Hillstrom, J.R.2
-
30
-
-
0029095589
-
Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu
-
Valone, F. H., Kaufman, P. A., Guyre, P. M., Lewis, L. D., Memoli, V., Deo, Y., Graziano, R., Fisher, J. L., Meyer, L., Mrozek-Orlowski, M., Wardwell, K., Guyre, V., Morley, T. L., Aroizu, C., and Fonger, M. W. Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu. J. Clin. Oncol., 13: 2281-2292, 1995.
-
(1995)
J. Clin. Oncol.
, vol.13
, pp. 2281-2292
-
-
Valone, F.H.1
Kaufman, P.A.2
Guyre, P.M.3
Lewis, L.D.4
Memoli, V.5
Deo, Y.6
Graziano, R.7
Fisher, J.L.8
Meyer, L.9
Mrozek-Orlowski, M.10
Wardwell, K.11
Guyre, V.12
Morley, T.L.13
Aroizu, C.14
Fonger, M.W.15
-
31
-
-
0029818654
-
Treatment of Hodgkin's disease with bispecific antibodies
-
Hartmann, F., Renner, C., Jung, W., Sahin, U., and Pfreundschuh, M. Treatment of Hodgkin's disease with bispecific antibodies. Ann. Oncol., 4: 143-146, 1996.
-
(1996)
Ann. Oncol.
, vol.4
, pp. 143-146
-
-
Hartmann, F.1
Renner, C.2
Jung, W.3
Sahin, U.4
Pfreundschuh, M.5
-
32
-
-
0030856803
-
CD3 x CD19 bispecific antibodies and CD28 costimulation for locoregional treatment of low-malignancy non-Hodgkin's lymphoma
-
Manzke, O., Titzer, S., Tesch, H., Diehl, V., and Bohlen, H. CD3 x CD19 bispecific antibodies and CD28 costimulation for locoregional treatment of low-malignancy non-Hodgkin's lymphoma. Cancer Immunol. Immunother., 45: 198-202, 1997.
-
(1997)
Cancer Immunol. Immunother.
, vol.45
, pp. 198-202
-
-
Manzke, O.1
Titzer, S.2
Tesch, H.3
Diehl, V.4
Bohlen, H.5
-
33
-
-
10344229501
-
Costimulation by CD28 sFv expressed on the tumor cell surface or as a soluble bispecific molecule targeted to the L6 carcinoma antigen
-
Hayden, M. S., Grosmaire, L. S., Norris, N. A., Gilliland, L. K., Winberg, G., Tritschler, D., Tsu, T. T., Linsley, P. S., Mittler, R. S., Senter, P. D., Fell, H. P., and Ledbetter, J. A. Costimulation by CD28 sFv expressed on the tumor cell surface or as a soluble bispecific molecule targeted to the L6 carcinoma antigen. Tissue Antigens, 48: p242-54, 1996.
-
(1996)
Tissue Antigens
, vol.48
, pp. 242-254
-
-
Hayden, M.S.1
Grosmaire, L.S.2
Norris, N.A.3
Gilliland, L.K.4
Winberg, G.5
Tritschler, D.6
Tsu, T.T.7
Linsley, P.S.8
Mittler, R.S.9
Senter, P.D.10
Fell, H.P.11
Ledbetter, J.A.12
-
34
-
-
0027078670
-
Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4
-
Chen, L., Ashe, S., Brady, W. A., Hellstrom, I., Hellstrom, K. E., Ledbetter, J. A., McGowan, P., and Linsley, P. S. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell, 71: 1093-1102, 1992.
-
(1992)
Cell
, vol.71
, pp. 1093-1102
-
-
Chen, L.1
Ashe, S.2
Brady, W.A.3
Hellstrom, I.4
Hellstrom, K.E.5
Ledbetter, J.A.6
McGowan, P.7
Linsley, P.S.8
-
35
-
-
0031569957
-
Costimulation of T cell proliferation by a chimeric B7-2 antibody fusion protein specifically targeted to cells expressing the erbB2 proto-oncogene
-
Gerstmayer, B., Altenschmidt, U., Hoffmann, M., and Wels, W. Costimulation of T cell proliferation by a chimeric B7-2 antibody fusion protein specifically targeted to cells expressing the erbB2 proto-oncogene. J. Immunol., 158: 4584-4590, 1997.
-
(1997)
J. Immunol.
, vol.158
, pp. 4584-4590
-
-
Gerstmayer, B.1
Altenschmidt, U.2
Hoffmann, M.3
Wels, W.4
-
36
-
-
0028078866
-
Phage libraries for generation of clinically useful antibodies
-
Chester, K. A., Begent, R. H. J., Robson, L., Keep, P., Pedley, R. B., Boden, J. A., Boxer, G., Green, A., Winter, G., Cochet, O., and Hawkins, R. E. Phage libraries for generation of clinically useful antibodies. Lancet, 343: 455-456, 1994.
-
(1994)
Lancet
, vol.343
, pp. 455-456
-
-
Chester, K.A.1
Begent, R.H.J.2
Robson, L.3
Keep, P.4
Pedley, R.B.5
Boden, J.A.6
Boxer, G.7
Green, A.8
Winter, G.9
Cochet, O.10
Hawkins, R.E.11
|